MEDIMMUNE
MedImmune develops medicines for unmet medical needs worldwide. As the global biologics research and development arm of AstraZeneca, MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic including respiratory, inflammation, and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. Since its founding in 1988, MedImmune has remained committed to scientific innovation and medical progress, continually looking beyond standard expectations and pushing the boundaries of what is possible.
MEDIMMUNE
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
1987-01-01
Address:
Maryland, Louisiana, United States
Country:
United States
Website Url:
http://www.astrazeneca.com
Total Employee:
5001+
Status:
Active
Contact:
301-398-0000
Technology used in webpage:
WordPress Wordpress Plugins IPv6 Microsoft Azure DNS PHP Amazon Route 53 Microsoft Japanese Yen Mimecast GlobalSign Domain Verification
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Bionorica SE
Bionorica SE develops and manufactures herbal medicines for customers worldwide.
Encysive Pharmaceuticals
Encysive Pharmaceuticals develops synthetic and small molecule compounds to address medical needs worldwide.
Hyland's
Hyland’s, Inc., a division of Standard Homeopathic Company.
ILEX Oncology,Inc.
ILEX is a drug development company focused exclusively on oncology.
Leica Biosystems
Leica Biosystems develops laboratory workflow solutions for anatomic pathology involved in the advancement of cancer diagnostics.
Nexien BioPharma
Nexien BioPharma develops cannabinoid based medications for specific medical conditions and disorders.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Sunlight
Sunlight develops technology that improves people's working lives.
Viramatix
We develop therapeutics for viral diseases of unmet medical need.
Current Employees Featured
Rakesh Dixit Vice President, R & D, Global Head, Biologics Safety Assessment @ MedImmune
Vice President, R & D, Global Head, Biologics Safety Assessment
Ed Mathers Executive Vice President, Corporate Development and Venture @ MedImmune
Executive Vice President, Corporate Development and Venture
Frank J. Malinoski Team Member @ MedImmune
Team Member
Cristina Rondinone Senior Vice President, Head Of Cardiovascular, Renal and Metabolic Diseases @ MedImmune
Senior Vice President, Head Of Cardiovascular, Renal and Metabolic Diseases
2019-01-01
Jhi Zhu Senior Scientist @ MedImmune
Senior Scientist
James Brown Director, IT Relationship Management, R&D @ MedImmune
Director, IT Relationship Management, R&D
2007-05-01
Michael Dittmer Associate Scientist, BioProcess Engineering @ MedImmune
Associate Scientist, BioProcess Engineering
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-11-04 | Definiens | Definiens acquired by MedImmune | 150 M USD |
| 2014-09-19 | Allozyne | Allozyne acquired by MedImmune | 5.5 M USD |
| 2013-10-15 | Spirogen | Spirogen acquired by MedImmune | 440 M USD |
| 2013-08-27 | Amplimmune | Amplimmune acquired by MedImmune | 500 M USD |
| 2013-04-03 | AlphaCore Pharma | AlphaCore Pharma acquired by MedImmune | N/A |
| 2005-09-15 | Cellective Therapeutics | Cellective Therapeutics acquired by MedImmune | 160 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-04-25 | Corvidia | MedImmune investment in Series B - Corvidia | 60 M USD |
| 2014-11-10 | MdBio Foundation | MedImmune investment in Grant - MdBio Foundation | 500 K USD |
| 2013-10-16 | ADC Therapeutics | MedImmune investment in Series B - ADC Therapeutics | 40 M USD |
Official Site Inspections
http://www.astrazeneca.com Semrush global rank: 3.13 M Semrush visits lastest month: 1.69 K
- Host name: ac9efcde36061855b.awsglobalaccelerator.com
- IP address: 15.197.255.153
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
